Surmodics, Inc. (SRDX)
Nov 19, 2025 - SRDX was delisted (reason: acquired by GTCR affiliate)
42.98
+0.15 (0.35%)
Inactive · Last trade price on Nov 18, 2025
Surmodics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| 120.8 | 126.08 | 132.58 | 99.95 | 105.14 | 94.86 | |
Revenue Growth (YoY) | -0.02% | -4.91% | 32.65% | -4.93% | 10.83% | -5.21% |
Cost of Revenue | 32.51 | 33.03 | 24.97 | 20.34 | 17.18 | 15.32 |
Gross Profit | 88.3 | 93.05 | 107.62 | 79.61 | 87.96 | 79.55 |
Selling, General & Admin | 62.55 | 56.84 | 51.88 | 46.94 | 30.68 | 28.39 |
Depreciation & Amortization Expenses | 3.51 | 3.5 | 3.54 | 4.15 | 2.79 | 2.22 |
Research & Development | 34.58 | 38.36 | 46.6 | 50.61 | 46.73 | 50.19 |
Other Operating Expenses | - | - | 0.45 | 0.01 | 1.05 | - |
Total Operating Expenses | 100.64 | 98.7 | 102.47 | 101.71 | 81.26 | 80.8 |
Operating Income | -12.35 | -5.65 | 5.15 | -22.1 | 6.7 | -1.25 |
Interest Expense | -4.83 | -5.46 | -4.57 | -0.7 | -0.43 | -0.79 |
Other Non-Operating Income (Expense) | -0.2 | -0.24 | -0.25 | 0.1 | -0.17 | -0.93 |
Total Non-Operating Income (Expense) | -5.03 | -5.71 | -4.82 | -0.59 | -0.6 | -1.72 |
Pretax Income | -14.69 | -7.51 | 2.49 | -22.49 | 6.35 | -1.45 |
Provision for Income Taxes | 2.94 | 4.04 | 4.02 | 4.78 | 2.11 | -2.58 |
Net Income | -17.63 | -11.54 | -1.54 | -27.27 | 4.24 | 1.12 |
Net Income to Common | -17.63 | -11.54 | -1.54 | -27.27 | 4.24 | 1.12 |
Net Income Growth | - | - | - | - | 277.29% | -85.21% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | 0.82% | 0.87% | 0.83% | -0.52% | 1.28% | 0.24% |
EPS (Basic) | -1.24 | -0.82 | -0.11 | -1.96 | 0.31 | 0.08 |
EPS (Diluted) | -1.24 | -0.82 | -0.11 | -1.96 | 0.30 | 0.08 |
EPS Growth | - | - | - | - | 275.00% | -85.45% |
Free Cash Flow | -3.55 | -3.24 | 7.6 | -20.59 | 10.11 | 10.34 |
Free Cash Flow Growth | - | - | - | - | -2.21% | 406.81% |
Free Cash Flow Per Share | -0.25 | -0.23 | 0.54 | -1.48 | 0.72 | 0.75 |
Gross Margin | 73.09% | 73.81% | 81.17% | 79.65% | 83.66% | 83.85% |
Operating Margin | -10.22% | -4.48% | 3.88% | -22.11% | 6.38% | -1.32% |
Profit Margin | -14.59% | -9.15% | -1.16% | -27.29% | 4.03% | 1.18% |
FCF Margin | -2.94% | -2.57% | 5.73% | -20.60% | 9.62% | 10.90% |
EBITDA | -3.88 | 3.05 | 13.67 | -12.96 | 14.72 | 6.01 |
EBITDA Margin | -3.21% | 2.42% | 10.31% | -12.96% | 14.00% | 6.34% |
EBIT | -12.35 | -5.65 | 5.15 | -22.1 | 6.7 | -1.25 |
EBIT Margin | -10.22% | -4.48% | 3.88% | -22.11% | 6.38% | -1.32% |
Effective Tax Rate | -19.98% | -53.77% | 161.76% | -21.26% | 33.23% | 177.24% |